Comparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 전용환 | - |
dc.contributor.author | 김승훈 | - |
dc.contributor.author | 최동일 | - |
dc.contributor.author | 김민주 | - |
dc.contributor.author | 김삼수 | - |
dc.contributor.author | 이지원 | - |
dc.contributor.author | 한헌 | - |
dc.contributor.author | 이종미 | - |
dc.date.accessioned | 2021-09-09T12:09:19Z | - |
dc.date.available | 2021-09-09T12:09:19Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1738-2637 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/124263 | - |
dc.description.abstract | Purpose: To compare the diagnostic performance of ferucarbotran-enhanced MRI at 1.5-T with triple-phase multidetector-row helical CT (MDCT) to detect hepatocellular carcinoma in patients with advanced liver cirrhosis. Materials and Methods: Twenty patients with advanced liver cirrhosis (Child's class B:C = 8:12) underwent ferucarbotran-enhanced MRI and triple-phase MDCT prior to liver transplantation. The mean time interval between the two imaging techniques was 18 days (range, 1-35 days). Three radiologists independently reviewed both images on a lesion-by-lesion basis and interpreted them for comparison with the pathologic findings of the explanted livers. As well, the sensitivity and an alternative-free response receiver operating characteristics (ROC) analysis was used to evaluate the diagnostic performance of each technique. Results: The mean area under the ROC curve (Az) was significantly higher for the triple-phase MDCT (0.766) compared to the ferucarbotran-enhanced MRI (0.675) (p < 0.001). Similarly, the mean sensitivity of the triple-phase MDCT (60.3%) exceeded the ferucarbotran-enhanced MRI (43.1%). The results indicate that the triple-phase MDCT provides significantly greater mean sensitivity than the ferucarbotran-enhanced MRI (p < 0.001). Conclusion: The triple-phase MDCT provided a better diagnostic performance and higher sensitivity than the ferucarbotran-enhanced MRI for the detection of hepatocellular carcinomas in patients with advanced liver cirrhosis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 대한영상의학회 | - |
dc.title | Comparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis | - |
dc.title.alternative | Comparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김민주 | - |
dc.contributor.affiliatedAuthor | 이종미 | - |
dc.identifier.bibliographicCitation | 대한영상의학회지, v.58, no.1, pp.53 - 63 | - |
dc.relation.isPartOf | 대한영상의학회지 | - |
dc.citation.title | 대한영상의학회지 | - |
dc.citation.volume | 58 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 53 | - |
dc.citation.endPage | 63 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001213644 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Carcinoma | - |
dc.subject.keywordAuthor | hepatocellular Liver cirrhosis Magnetic resonance (MR) Tomography | - |
dc.subject.keywordAuthor | spiral computed Ferumoxides | - |
dc.subject.keywordAuthor | Carcinoma | - |
dc.subject.keywordAuthor | hepatocellular Liver cirrhosis Magnetic resonance (MR) Tomography | - |
dc.subject.keywordAuthor | spiral computed Ferumoxides | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.